Whole Exome Sequencing of Familial and Pediatric Forms of Vasculitis
ConditionVasculitis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorBenjamin Terrier
About this trial
The FAMILYVASC study is a prospective observational study which will aim to identify susceptibility loci and genes for systemic vasculitis risk in patients with familial or pediatric forms of vasculitis. Genetic analysis based on whole exome sequencing will be carried out through salivary DNA.
Eligibility criteria
Qualifiers
Children and adults
Patients with vasculitis, as defined in the Chapel Hill International Classification in its revised version of 2012
Patient information and signed informed consent
Pregnant and breastfeeding women can be included in the study
Disqualifiers
Refusal of consent or inability to obtain consent
Dementia or unauthorized patient, for psychiatric or intellectual failure reasons, to receive information about the protocol and to give informed consent.
Uncooperative patient, or any pathology that could make the patient potentially non-compliant to the study procedures, and patients interned for regulatory or legal reasons.
Trial design
Treatments tested in this trial
- genetic analysis
Treatment groups
No treatment groups listed
Sponsors and collaborators
Benjamin Terrier
Lead sponsor
French Vasculitis Study Group
Sponsor institution
Source ClinicalTrials.gov